Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Xbiotech Inc (XBIT)

Xbiotech Inc (XBIT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
XBiotech: Q3 Earnings Snapshot AP - Wed Nov 12, 2025

XBiotech: Q3 Earnings Snapshot

XBIT : 2.45 (+3.38%)
XBiotech Signs New Executive Agreement with CEO Tipranks - Sat Oct 4, 2025

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An announcement...

XBIT : 2.45 (+3.38%)
XBiotech: Q2 Earnings Snapshot AP - Wed Aug 13, 2025

XBiotech: Q2 Earnings Snapshot

XBIT : 2.45 (+3.38%)
XBiotech: Q1 Earnings Snapshot AP - Wed May 14, 2025

XBiotech: Q1 Earnings Snapshot

XBIT : 2.45 (+3.38%)
XBiotech Pauses Rheumatology program GlobeNewswire - Mon Dec 23, 2024

XBIT : 2.45 (+3.38%)
XBiotech: Q3 Earnings Snapshot AP - Wed Nov 13, 2024

XBiotech: Q3 Earnings Snapshot

XBIT : 2.45 (+3.38%)
Junior Biotech Utilizes AI To Shorten Drug Discovery Timelines, Ultimately Saving Lives Yolowire - Tue Sep 10, 2024

The urgent need for innovative technologies to accelerate the development of life-saving %Cancer therapies has never been more critical. With millions of lives and billions of dollars at stake, the potential...

MRK : 121.41 (+1.82%)
NVS : 163.10 (+1.19%)
RHHBY : 58.5100 (-0.17%)
AZN : 205.55 (+0.50%)
BMRN : 59.87 (-0.12%)
KTRA : 0.2154 (-6.31%)
XBIT : 2.45 (+3.38%)
RKV.VN : 0.175 (+9.38%)
XBiotech: Q2 Earnings Snapshot AP - Mon Aug 12, 2024

XBiotech: Q2 Earnings Snapshot

XBIT : 2.45 (+3.38%)
XBiotech: Q1 Earnings Snapshot AP - Fri May 10, 2024

XBiotech: Q1 Earnings Snapshot

XBIT : 2.45 (+3.38%)
XBiotech Announces Successful Completion of Phase I portion of Pancreatic Cancer Study Globe Newswire - Mon Jun 20, 2022

Novel Natrunix Treatment Shows Promise in Combination Chemotherapy for Treatment of Pancreatic Cancer...

XBIT : 2.45 (+3.38%)

Barchart Exclusives

AI Disruption Fear, FOMS and Other Key Things to Watch this Week Barchart - 11 minutes ago
Markets enter a holiday-shortened week as AI disruption fears that initially pressured software stocks have spread dramatically to wealth management, commercial real estate firms, and logistics companies. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot